MLICM
IDXX icon

Metropolitan Life Insurance Company (MetLife)’s Idexx Laboratories IDXX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,350
Closed -$1.81M – 1011
2024
Q1 		$1.81M Sell
3,350
-33
-1% -$18K 0.08% 213
2023
Q4 		$1.88M Sell
3,383
-52
-2% -$24.4K 0.09% 196
2023
Q3 		$1.5M Sell
3,435
-183
-5% -$91.3K 0.08% 223
2023
Q2 		$1.82M Sell
3,618
-86
-2% -$41.2K 0.09% 194
2023
Q1 		$1.85M Sell
3,704
-991
-21% -$474K 0.1% 191
2022
Q4 		$1.92M Sell
4,695
-141
-3% -$54.7K 0.09% 232
2022
Q3 		$1.58M Sell
4,836
-103
-2% -$37.8K 0.07% 261
2022
Q2 		$1.73M Sell
4,939
-171
-3% -$69.7K 0.08% 246
2022
Q1 		$2.8M Sell
5,110
-8,402
-62% -$4.42M 0.1% 190
2021
Q4 		$8.9M Sell
13,512
-293
-2% -$184K 0.12% 132
2021
Q3 		$8.59M Sell
13,805
-14,792
-52% -$9.94M 0.12% 131
2021
Q2 		$18.1M Buy
28,597
+13,869
+94% +$7.66M 0.13% 126
2021
Q1 		$7.21M Sell
14,728
-843
-5% -$422K 0.11% 152
2020
Q4 		$7.78M Sell
15,571
-589
-4% -$264K 0.12% 145
2020
Q3 		$6.35M Sell
16,160
-643
-4% -$238K 0.11% 153
2020
Q2 		$5.55M Buy
16,803
+191
+1% +$55.3K 0.1% 166
2020
Q1 		$4.02M Sell
16,612
-238
-1% -$62.1K 0.08% 196
2019
Q4 		$4.4M Sell
16,850
-129
-0.8% -$34K 0.07% 237
2019
Q3 		$4.62M Sell
16,979
-15
-0.1% -$4.17K 0.08% 227
2019
Q2 		$4.68M Buy
16,994
+866
+5% +$213K 0.08% 222
2019
Q1 		$3.61M Sell
16,128
-653
-4% -$135K 0.07% 247
2018
Q4 		$3.12M Sell
16,781
-119
-0.7% -$24.4K 0.06% 253
2018
Q3 		$4.22M Sell
16,900
-425
-2% -$103K 0.07% 226
2018
Q2 		$3.78M Buy
17,325
+62
+0.4% +$12.8K 0.06% 253
2018
Q1 		$3.3M Hold
17,263
– – 0.05% 296
2017
Q4 		$2.7M Sell
17,263
-27,870
-62% -$4.39M 0.04% 369
2017
Q3 		$7.02M Sell
45,133
-959
-2% -$152K 0.04% 375
2017
Q2 		$7.44M Sell
46,092
-826
-2% -$134K 0.05% 345
2017
Q1 		$7.25M Sell
46,918
-40,388
-46% -$5.57M 0.05% 375
2016
Q4 		$10.2M Sell
87,306
-429
-0.5% -$49K 0.07% 252
2016
Q3 		$9.89M Sell
87,735
-397
-0.5% -$41.8K 0.07% 260
2016
Q2 		$8.18M Buy
88,132
+2,490
+3% +$214K 0.06% 298
2016
Q1 		$6.71M Buy
85,642
+1,168
+1% +$84.1K 0.05% 371
2015
Q4 		$6.16M Sell
84,474
-366
-0.4% -$26.1K 0.05% 403
2015
Q3 		$6.3M Sell
84,840
-2,064
-2% -$148K 0.05% 395
2015
Q2 		$5.57M Buy
+86,904
New +$6.02M 0.04% 478
2015
Q1 		– Sell
-84,994
Closed -$6.3M – 2312
2014
Q4 		$6.3M Sell
84,994
-3,824
-4% -$268K 0.04% 425
2014
Q3 		$5.23M Sell
88,818
-1,156
-1% -$73.1K 0.04% 478
2014
Q2 		$6.01M Sell
89,974
-674
-0.7% -$42.9K 0.04% 452
2014
Q1 		$5.5M Buy
90,648
+1,174
+1% +$69.9K 0.04% 487
2013
Q4 		$4.76M Sell
89,474
-678
-0.8% -$35.7K 0.03% 539
2013
Q3 		$4.49M Sell
90,152
-1,470
-2% -$70.7K 0.03% 531
2013
Q2 		$4.11M Buy
+91,622
New +$4M 0.03% 522

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IDXX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 3,350 shares — an estimated $1.81M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IDXX in Q2 2013 and held it in 43 quarters. The position peaked at $18.1M in Q2 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,350 Idexx Laboratories shares in Q2 2024, an estimated $1.81M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Idexx Laboratories in Q2 2013 and held it in 43 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Idexx Laboratories position peaked at $18.1M in Q2 2021.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.